Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Glioma 4Glioblastoma 4Melanoma 3Leukemia, Myeloid, Acute 3Sarcoma 2Colorectal Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Astrocytoma 2Treatment 1Stomach Neoplasms 1Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1Rhabdomyosarcoma 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Peritoneal Neoplasms 1Pathologic Complete Response 1Neurofibrosarcoma 1Neoplasms, Connective and Soft Tissue 1Neoplasms 1Neoplasm Metastasis 1Myosarcoma 1Microsatellite Instability 1Lung Neoplasms 1Liposarcoma 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia 1Leiomyosarcoma 1

Interventions

Cyclophosphamide 46fludarabine phosphate 34Peripheral Blood Stem Cell Transplantation 29Whole-Body Irradiation 22Etoposide 22Tacrolimus 20Methotrexate 20Mycophenolic Acid 19Cytarabine 19Dexamethasone 17Vincristine 16Filgrastim 16Busulfan 16venetoclax 15Antilymphocyte Serum 15Rituximab 13Prednisone 13Cyclosporine 12Doxorubicin 11Melphalan 9Calcium Dobesilate 9nelarabine 8Bortezomib 8merphos 7Radiotherapy 7Methylprednisolone 7Granulocyte Colony-Stimulating Factor 7Azacitidine 7prednylidene 6pegaspargase 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Precursor T-Cell Lymphoblastic Leukemia-Lymphoma × lentiviral minigene vaccine of COVID-19 coronavirus × Clear all
NCT05321940 2023-12-04

Safety Trial of STING-dependent Activators and Stimulated Dendritic Cells for Aggressive Relapsed/Refractory Leukemias

University of Miami

Phase 1 Withdrawn
LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡